## Review

### Scores

| Criterion | Score (0–100) | Assessment |
|---|---:|---|
| **Soundness** | **40** | The task and model are plausible, and the reported experiments include two datasets, ablation, and multiple baselines. However, important methodological details are missing. The paper does not clearly specify sepsis-label construction, whether cultures, antibiotics, or other label-defining events are excluded from the input, how onset time is determined, how multiple measurements within hourly windows are aggregated, or how missing values and initial time intervals are handled. These omissions raise substantial concerns about label leakage and reproducibility. The use of baseline hyperparameters from original papers rather than comparable tuning is also potentially unfair. No confidence intervals, statistical tests, calibration analysis, or patient-level prediction details are provided. |
| **Novelty** | **45** | Combining RETAIN-style two-level attention with learned interval decay is a reasonable engineering contribution, but the conceptual novelty is limited. Time-aware handling of irregular EHR observations is already central to GRU-D and related models. The paper does not clearly establish how TimeWarn differs mathematically or empirically from applying decay to inputs or hidden states, nor does it provide sufficiently extensive ablations to isolate the contribution of the proposed attention modulation. |
| **Significance** | **55** | Early sepsis prediction is clinically important, and performance improvements on both MIMIC-IV and eICU could be meaningful. Nevertheless, the gains over GRU-D are modest, and the study is entirely retrospective. There is no analysis of calibration, alert burden, sensitivity at clinically relevant operating points, subgroup performance, or prospective clinical utility. The restriction to U.S. ICU data limits immediate generalizability. |
| **Clarity** | **76** | The paper is well organized and generally easy to read. The motivation, architecture, and headline results are presented clearly. However, several details needed for implementation and evaluation are underspecified, including cohort construction, label timing, preprocessing, imputation, window aggregation, exact attention equations, and baseline training procedures. The interpretation of attention weights as clinically meaningful evidence is also stated more strongly than justified by the analysis. |

### Final average

\[
\frac{40 + 45 + 55 + 76}{4} = \mathbf{54.0}
\]

## Recommendation: **Reject**

The paper addresses an important problem and presents a coherent model with promising reported results. However, the current version does not provide enough methodological detail or validation to establish that the improvements are reliable. The most serious concerns are possible leakage from sepsis-label-defining events, insufficient specification of the data-processing and onset-labeling pipeline, limited differentiation from existing time-aware models such as GRU-D, and lack of statistical and clinical utility analyses.

A revised submission should clarify the complete label-generation and censoring procedure, explicitly prevent leakage, tune baselines under a comparable protocol, report confidence intervals and operating-point metrics, provide stronger ablations, and evaluate calibration, subgroup robustness, and alert burden.